Clinical Trials Logo
  1. Home
  2. Steatohepatitis, Nonalcoholic
  3. NCT04707651

Formula Diet Treatment for NASH Patients. — NASH  

Steatohepatitis, Nonalcoholic Clinical Trial

Official title:
Formula Diet Treatment for Weight Reduction in NASH Patients.

Clinical Trial Summary

Non-alcoholic steatohepatitis (NASH) - also called fatty liver - is medically a serious problem because the liver tissue becomes fatty and stiff, and inflammatory reactions occur. This increases the risk of liver fibrosis (= scarring of the liver), liver cirrhosis (= shrunken liver), a liver tumor or death. So far there is no recognized treatment option for this disease. However, there is evidence that a lifestyle change based on a reduced carbohydrate diet, more exercise and a significant weight loss that can improve NASH.

Clinical Trial Description

Outpatients with NASH will be included into this lifestyle intervention study. Patients will get nutritional advices and a formula diet for 12 weeks. Clinical visits will take place at baseline, after 4, 12 and after 52 weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04707651
Study type Interventional
Source West German Center of Diabetes and Health
Contact Stephan Martin, MD
Phone +49(0)211-5660360
Email stephan.martin@uni-duesseldorf.de
Status Recruiting
Phase N/A
Start date January 18, 2021
Completion date March 31, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04861012 - Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt N/A
Not yet recruiting NCT06302049 - Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitis Phase 1/Phase 2
Completed NCT04932512 - A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224 Phase 2
Completed NCT03915002 - Integrated Approaches for Identifying Molecular Targets in Liver Disease
Terminated NCT04175392 - Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis Phase 1/Phase 2
Recruiting NCT04785937 - Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients N/A
Active, not recruiting NCT05946330 - Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). N/A
Terminated NCT04284371 - The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients
Completed NCT04080947 - The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis Phase 1/Phase 2